| Cholinesterase inhibitors are important drugs for managing patients in all stages of dementia with Lewy bodies (DLB), since they improve global cognitive function and reduce visual hallucinations and other behavioral symptoms. |
| New data from a recent phase 2 clinical trial have demonstrated the effectiveness of zonisamide when used as an adjunct to levodopa in treating the parkinsonism associated with DLB. |
| Rapid eye movement sleep behavior disorder, a condition that may precede dementia and other core features of DLB, is often responsive to either melatonin or clonazepam. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.